Chapter 3 – Investigation of Male Infertility




Abstract




Male factor infertility is a contributory factor for approximately 50% of couples that present seeking investigation and treatment for infertility, either in isolation (25%) or in combination with a female factor (25%) [1]. Therefore an accurate and complete investigation of the male partner is essential in assessing all couples with infertility. A significant number of male factors are either reversible or amenable to treatment provided that an accurate assessment and diagnosis is made.





Chapter 3 Investigation of Male Infertility


Arie Parnham and Asif Muneer



1 Introduction


Male factor infertility is a contributory factor for approximately 50% of couples that present seeking investigation and treatment for infertility, either in isolation (25%) or in combination with a female factor (25%) [1]. Therefore an accurate and complete investigation of the male partner is essential in assessing all couples with infertility. A significant number of male factors are either reversible or amenable to treatment provided that an accurate assessment and diagnosis is made.


The aims of evaluation, some of which are also mentioned in the American Urological Association (AUA) guidelines are to correctly identify the following:




  • Potentially reversible conditions contributing to male infertility either due to obstruction within the reproductive tract or treatment of endocrinopathies



  • Irreversible conditions amenable to assisted reproductive techniques using the sperm of the male partner



  • Irreversible conditions that are not open to the above, and for which donor insemination or adoption are possible options



  • Life- or health-threatening conditions that may underlie the infertility and require medical attention



  • Genetic abnormalities that may affect the health of offspring if assisted reproductive techniques are to be employed [2].



2 Definitions


Male factor infertility has a number of definitions, which to the casual or novice investigator can be both confusing and novel. It is important however to have a firm understanding of each term as this underpins the subsequent categorisation of patients and management. Table 3.1 lists common terms employed and their definitions:




Table 3.1 Common terms and definitions based on the WHO 5th edition laboratory manual in 2010[35]


































Term Definition
Infertility Infertility is the inability of a sexually active, non-contracepting couple to achieve spontaneous pregnancy within one year
Primary infertility When a woman is unable to ever bear a child, either due to the inability to become pregnant or the inability to carry a pregnancy to a live birth, she would be classified as having primary infertility. Thus women whose pregnancy miscarries or whose pregnancy results in a stillborn child, without ever having had a live birth, would present with primary infertility.
Secondary infertility A woman who is unable to bear a child, either due to the inability to become pregnant or due to the inability to carry a pregnancy to a live birth (following either a previous pregnancy or a previous ability to carry a pregnancy to a live birth) would be classified as having secondary infertility. Therefore those who repeatedly spontaneously miscarry or whose pregnancy results in a stillbirth, or following a previous pregnancy or a previous ability to do so, are then not unable to carry a pregnancy to a live birth would present with secondary infertility. This definition depends on the birth of the first child not involving any assisted reproductive technologies or fertility medications.
Oligozoospermia <15×106 spermatozoa per milliliter
Severe Oligozoospermia <5×106 spermatozoa per milliliter
Azoospermia no spermatozoa in the ejaculate (given as the limit of quantification for the assessment method employed)
Asthenozoospermia <32% sperm progressively motile
Teratozoospermia <4% normal forms on morphology


3 Causes of Male Factor Infertility


When considering the investigations for male factor infertility it is imperative to have a clear understanding of the potential underlying causes. The causes of male infertility can be broadly categorised as follows:




  • Idiopathic



  • Congenital or acquired urogenital abnormalities



  • Malignancies



  • Urogenital infections



  • Abberations that impair temperature control such as varicocele



  • Endocrine dysfunction



  • Genetic abnormalities



  • Immunological factors [4].


Idiopathic male infertility is the most commonly found cause with abnormal semen parameters (30–40%). Table 3.2 provides an overview of the frequency of individual disorders as they may occur in a large fertility centre.




Table 3.2 [6] Percentage distribution of diagnoses of 12,945 patients attending the Institute of Reproductive Medicine of the University of Munster based on the clinical databank Androbase®. 1,446(=11.2%) of these patients were azoospermic. In the event of several diseases, only the leading diagnosis was included




























































































































































Diagnosis Unselected patients N=12,945 Azoospermic patients N=1,446
All 100% 11.2%
Infertility of (known) possible cause 42.6% 42.6%
Maldescended testes (current/former) 8.4 17.2
Varicocele 14.8 10.9
Infection 9.3 10.5
Autoantibodies against sperm 3.9
Testicular tumour 1.2 2.8
Idiopathic infertility 30.0 13.3
Hypogonadism 10.1 16.4
Klinefelter syndrome (47, XXY) 2.6 13.7
XX-male 0.1 0.6
Primary hypogonadism of unknown cause 2.3 0.8
Secondary (hypogonadotrophic) hypogonadism 1.6 1.9
Kallmann syndrome 0.3 0.5
Idiopathic hypogonadotrophic hypogonadism 0.4 0.4
Residual after pituitary surgery <0.1 0.3
Others 0.8 0.8
Late onset hypogonadism 2.2
Constitutional delay of puberty 1.4
General systemic disease 2.2 0.5
Cryopreservation due to malignant disease 7.8 12.5
Testicular tumour 5.0 4.3
Lymphoma 1.5 4.6
Leukaemia 0.7 2.2
Sarcoma 0.6 0.9
Disturbances of erection/ejaculation 2.4
Obstruction 2.2 10.3
Vasectomy 0.9 5.3
Cystic fibrosis, CBAVD 0.5 3.1
Others 0.8 1.9
Gynaecomastia 1.5 0.2
Y-Chromosomal deletion 0.3 1.6
Other Chromosomal abberations 0.2 1.3
Translocations 0.1 0.3
Others <0.1 0.3
Others 0.7 1.3


4 Timing of Investigation


It is generally agreed that patients should be referred for further investigations if they meet the definition for infertility as defined earlier. However a number of national bodies, including the National Institute of Clinical Excellence (NICE) and the AUA, agree that there are certain circumstances where this can be circumvented. Such circumstances include the following: 1) female partner 36 years old and over; 2) a known clinical cause of infertility or a history of predisposing factors; 3) where treatment is planned that may result in infertility (for example therapy for malignancy); 4) where the couple or individuals question their fertility potential including even in the absence of a partner (AUA only) [2, 7].



5 History and Examination



5.1 History


A thorough history should be taken and should specifically include the following.



5.1.1 Reproductive History

The duration, frequency, timing and success of attempted conception should be noted along with conceptions with previous partners to allow correct characterisation of the infertility and whether or not they meet the definition given earlier. The clinician should attempt to categorise whether the patient or couple is suffering from primary or secondary infertility as this will determine the investigations required and future options for fertility treatment (See definitions in Table 3.1).



5.1.2 Sexual History

Issues around sexual dysfunction should be explored thoroughly and include erectile dysfunction, premature ejaculation, penile curvature (Peyronie’s disease or congenital curvature), changes in libido and orgasmic/ejaculatory function.


The use of contraception and lubricants should be identified as some have been identified as affecting sperm quality [8].


A thorough history should include previous sexually transmitted diseases (STDs) if any and their treatment.



5.1.3 Current General Health

Acute illness can have a profound effect on male fertility and sperm parameters. However, sperm parameters at the time of illness can be normal and only deteriorate several weeks later since the normal human spermatogenesis cycle is 64 days + 5–10 days for epididymal sperm transit.


Symptoms such as headaches, galactorrhea or impairment of the visual fields may be indicative of pituitary lesions.



5.1.4 Childhood Illnesses and Developmental Issues

A number of illnesses in childhood can affect fertility and a careful history combined with examination should identify these patients.


There is ongoing controversy regarding the relevance of a childhood history of unilateral undescended testis (UDT), as, despite having impaired semen parameters in adulthood, the paternity rate of such men is the same as that of men with bilateral descended testes. The same, however, cannot be said for those with bilateral undescended testes [9, 10].


Mumps orchitis, testicular torsion and inguinal surgery are also risk factors for male factor infertility and should be considered in the differential diagnosis.


The onset or delay of puberty can also suggest an endocrinological or genetic basis for male infertility.



5.1.5 Past Medical and Surgical History

Previous genitourinary infections including orchitis, epididymitis, prostatitis or sexually transmitted diseases should be investigated. Post pubertal infection with mumps when associated with orchitis increases the likelihood of male infertility.


Chronic medical conditions can also be associated with infertility. Patients with chronic renal disease diabetes and multiple sclerosis may be infertile and have a higher incidence of erectile dysfunction.



5.1.6 Medications

A number of medications are known to affect fertility and a selection of the common ones is listed in Table 3.3.




Table 3.3 Medications and their effects on male fertility (data from [11])
















































































Class of medication Effect on male fertility Example
Alpha-blockers Ejaculatory dysfunction Tamsulosin

Alfuzosin
Anabolic steroids Hypogonadism
Androgens Inhibited spermatogenesis Testosterone
Anti-inflammatory Impaired spermatogenesis Sulfasalazine
Antiandrogens Reduced erectile function

Reduced libido

Suppression of gonadotrophin secretion
Cyproterone Acetate
Antibiotics, antimycotics Impaired spermatogenesis

Hypogonadism
Tetracycline, Chloroquine, Erythromycin,

Co-Trimoxazole

Gentamicin

Ketoconazole
Antidepressants Effects on spermatogenesis and motility Imipramine
Antiepileptics Hypogonadism

Effects on spermatogenesis
Carbamazepine

Sodium Valporate
Beta blockers Erectile dysfunction

Inhibit sperm motility
Propanolol
Calcium channel blockers Inhibit sperm motility

Inhibit acrosome reaction
Nifedipine

Verapamil
Chemotherapy Impaired spermatogenesis

Hypogenadism
Alkylinating agents (Cyclophosphamide)

Cisplatin
Dopamine receptor antagonist Hyperprolactinaemia Metoclopramide
Gonadotrophin releasing hormone Hypogonadism
Histamine receptor blockers Gonadotoxic

Centrally acting effect on reproductive hormones
Cimetidine

Ranitidine
Immunosuppressants Impaired spermatogenesis

Hypogonadism

Reduced motility
Cyclosporin A

Tacrolimus
Opiates Hypogonadism Morphine
Retinoid Impaired spermatogenesis Isotretinoin


5.1.7 Family History

This is covered later in Section 7.3.



6 Examination



6.1 General Examination


An assessment of the patient’s general condition should be documented. Fat distribution, presence of gynaecomastia and hair patterns may be related to underlying hormonal or metabolic abnormalities. Klinefelter’s syndrome should be considered in patients who are tall with gynaeacomastia and bilateral low volume testes, however they may be phenotypically normal apart from the small volume testicles.



6.2 Genital Examination


This should include both an examination of the penis and scrotum including the scrotal contents.


The penile length should be assessed by measuring the stretched penile length from the symphysis pubis to the coronal sulcus or meatus. A small penis and testes can be a sign of Kallmann’s syndrome. Any plaques that may represent Peyronie’s disease should be identified and documented as this may cause issues with penetrative intercourse and erectile dysfunction. The urethral meatus should be examined to check for meatal stenosis or hypospadias and the foreskin checked to see if it is easily retractile or if it is phimotic.


The scrotum should be examined in a warm environment and in both the lying and standing positions. The clinician should proceed in a logical manner starting on one side and completing the examination of one hemiscrotum before moving to the contralateral side. Each structure should be identified and described as below.



6.2.1 Testes

The testes should be examined individually. Two hands should be used with the thumb and forefinger of each being used to isolate and roll over the surface of the testis. Comment should be made on the size, which can be formally assessed using either an orchidometer or callipers. Any masses should be noted as well as the consistency of the testes.



6.2.2 Epididymis

The epididymis should be palpated in a similar manner to the testicles. Dilatation of the epididymis may suggest obstruction, inflammation or infection.



6.2.3 Vas Deferens

The vas deferens should be identified and palpated along its length within the scrotum. A defect in the vas should be palpable after a vasectomy or the vas may be completely absent either unilaterally or bilaterally. Absence of the vas is usually associated with a genetic mutation. Unilateral absence of the vas is associated with an ipsilateral absent kidney whereas bilateral absent vasa, CBAVD (Congenital Bilateral Absence of Vas Deferens) is associated with mutations in the Cystic Fibrosis Transmembrane Regulator gene (CFTR).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 26, 2020 | Posted by in GYNECOLOGY | Comments Off on Chapter 3 – Investigation of Male Infertility

Full access? Get Clinical Tree

Get Clinical Tree app for offline access